Back to video list Back to Home Treatment duration in Bipolar Disorder & Schizophrenia You may also like Migraine Congress highlights Article Insights into neural pathways in migraine Alzheimer's Disease Article High Mobility Group Box 1 (HMGB1) in Vascular Dementia: Mechanism, Biomarker Potential, and Therapeutic Implication Schizophrenia Article Treatment-resistant schizophrenia – results of a survey on its clinical impact and therapeutic strategies Depression Schizophrenia Article Making primary care count in mental health provision
